Woodworth Emily 4
4 · BOSTON SCIENTIFIC CORP · Filed Mar 5, 2025
Insider Transaction Report
Form 4
Woodworth Emily
SVP, Global Controller and CAO
Transactions
- Exercise/Conversion
Common Stock
2025-03-03$37.50/sh+5,949$223,088→ 8,063 total - Sale
Common Stock
2025-03-03$104.97/sh−7,149$750,465→ 914 total - Sale
Common Stock
2025-03-04$104.63/sh−482$50,432→ 432 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-03-03−5,949→ 2,383 totalExercise: $37.50Exp: 2031-02-17→ Common Stock (5,949 underlying)
Footnotes (3)
- [F1]The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 29, 2024.
- [F2]Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $104.85 to $105.00, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.